- Home
- CREV vs ADTX Comparison
CREV vs ADTX Comparison
Compare CREV & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- ADTX
- Stock Information
- Founded
- CREV 2007
- ADTX 2017
- Country
- CREV Ireland
- ADTX United States
- Employees
- CREV N/A
- ADTX N/A
- Industry
- CREV
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- CREV
- ADTX Health Care
- Exchange
- CREV Nasdaq
- ADTX Nasdaq
- Market Cap
- CREV 5.7M
- ADTX 5.3M
- IPO Year
- CREV N/A
- ADTX 2020
- Fundamental
- Price
- CREV $2.80
- ADTX $1.54
- Analyst Decision
- CREV
- ADTX
- Analyst Count
- CREV 0
- ADTX 0
- Target Price
- CREV N/A
- ADTX N/A
- AVG Volume (30 Days)
- CREV 421.2K
- ADTX 109.4K
- Earning Date
- CREV 05-14-2025
- ADTX 05-15-2025
- Dividend Yield
- CREV N/A
- ADTX N/A
- EPS Growth
- CREV N/A
- ADTX N/A
- EPS
- CREV N/A
- ADTX N/A
- Revenue
- CREV $39,261,077.00
- ADTX $55,323.00
- Revenue This Year
- CREV $40.76
- ADTX $15,768.94
- Revenue Next Year
- CREV $86.18
- ADTX N/A
- P/E Ratio
- CREV N/A
- ADTX N/A
- Revenue Growth
- CREV 41.52
- ADTX N/A
- 52 Week Low
- CREV $2.00
- ADTX $1.34
- 52 Week High
- CREV $14.19
- ADTX $27,200.00
- Technical
- Relative Strength Index (RSI)
- CREV 41.58
- ADTX 35.55
- Support Level
- CREV $2.75
- ADTX $1.42
- Resistance Level
- CREV $3.20
- ADTX $1.63
- Average True Range (ATR)
- CREV 0.30
- ADTX 0.13
- MACD
- CREV -0.06
- ADTX 0.13
- Stochastic Oscillator
- CREV 5.11
- ADTX 40.82
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.